Aldeyra Therapeutics, Inc.ALDXNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-53.68M
↓ 36% below average
Average (9y)
$-39.36M
Historical baseline
Range
High:$-11.96M
Low:$-61.44M
CAGR
+18.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-53.68M | -52.5% |
| 2023 | $-35.21M | +41.4% |
| 2022 | $-60.07M | -7.7% |
| 2021 | $-55.77M | -54.6% |
| 2020 | $-36.07M | +41.3% |
| 2019 | $-61.44M | -58.9% |
| 2018 | $-38.67M | -74.3% |
| 2017 | $-22.19M | -19.6% |
| 2016 | $-18.56M | -55.2% |
| 2015 | $-11.96M | - |